UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation.
about
UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
UGT1A1 genotype-dependent dose ...... netic modeling and simulation.
@en
UGT1A1 genotype-dependent dose ...... netic modeling and simulation.
@nl
type
label
UGT1A1 genotype-dependent dose ...... netic modeling and simulation.
@en
UGT1A1 genotype-dependent dose ...... netic modeling and simulation.
@nl
prefLabel
UGT1A1 genotype-dependent dose ...... netic modeling and simulation.
@en
UGT1A1 genotype-dependent dose ...... netic modeling and simulation.
@nl
P2093
P2860
P356
P1476
UGT1A1 genotype-dependent dose ...... inetic modeling and simulation
@en
P2093
Cody J Peer
Jane B Trepel
Min-Jung Lee
Richard Piekarz
Sheryl Erlich
Susan E Bates
Tristan M Sissung
William D Figg
Yusuke Tomita
P2860
P304
P356
10.1002/JCPH.627
P577
2015-12-04T00:00:00Z